Division of Infectious Diseases, Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Occupational and Environmental Medicine, Department of Clinical and Experimental Medicine, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1223-1234. doi: 10.1007/s10096-019-03529-8. Epub 2019 Mar 25.
Early appropriate antimicrobial therapy is crucial in patients with sepsis and septic shock. Studies often focus on time to first dose of appropriate antibiotics, but subsequent dosing is equally important. Our aim was to investigate the impact of fulfillment of early treatment, with focus on appropriate administration of first and second doses of antibiotics, on 28-day mortality in patients with community-onset severe sepsis and septic shock. A retrospective study on adult patients admitted to the emergency department with community-onset sepsis and septic shock was conducted 2012-2013. The criterion "early appropriate antibiotic treatment" was defined as administration of the first dose of adequate antibiotics within 1 h, and the second dose given with less than 25% delay after the recommended dose interval. A high-risk patient was defined as a septic patient with either shock within 24 h after arrival or red triage level on admittance according to the Medical Emergency Triage and Treatment System Adult. Primary endpoint was 28-day mortality. Of 90 patients, less than one in four (20/87) received early appropriate antibiotic treatment, and only one in three (15/44) of the high-risk patients. The univariate analysis showed a more than threefold higher mortality among high-risk patients not receiving early appropriate antibiotic treatment. Multivariable analysis identified early non-appropriate antibiotic treatment as an independent predictor of mortality with an odds ratio for mortality of 10.4. Despite that the importance of early antibiotic treatment has been established for decades, adherence to this principle was very poor.
早期适当的抗菌治疗对脓毒症和感染性休克患者至关重要。研究通常侧重于首次使用适当抗生素的时间,但后续给药同样重要。我们的目的是调查早期治疗(重点是适当给予抗生素的首剂和第二剂)对社区获得性严重脓毒症和感染性休克患者 28 天死亡率的影响。2012-2013 年对因社区获得性脓毒症和感染性休克而入住急诊的成年患者进行了一项回顾性研究。“早期适当抗生素治疗”的标准定义为在 1 小时内给予首剂足够的抗生素,并且在推荐的剂量间隔后不到 25%的延迟给予第二剂。高危患者被定义为到达后 24 小时内出现休克或根据医疗急救分类和治疗系统成人标准分诊级别为红色的脓毒症患者。主要终点为 28 天死亡率。在 90 名患者中,不到四分之一(20/87)接受了早期适当的抗生素治疗,只有三分之一(15/44)的高危患者接受了早期适当的抗生素治疗。单因素分析显示,未接受早期适当抗生素治疗的高危患者死亡率高出三倍以上。多变量分析确定早期非适当抗生素治疗是死亡率的独立预测因素,死亡率的优势比为 10.4。尽管几十年来已经确立了早期抗生素治疗的重要性,但对这一原则的遵循情况非常差。